SCHEMBL8332767

SCHEMBL8332767

CCc1cccc([C@@H]2C[C@H]2C(=O)N(C)C2CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 1/20 0.46
▸ APP P05067 1/20 0.42
▸ CYP4F2 P78329 1/20 0.42
▸ CYP4A11 Q02928 1/20 0.42
▸ SLC5A1 P13866 1/20 0.41
▸ SLC5A2 P31639 1/20 0.41
▸ GPR88 Q9GZN0 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPY2R P49146 3/20 0.38
▸ SIGMAR1 Q99720 1/20 0.36
▸ SMYD3 Q9H7B4 1/20 0.36
▸ TACR1 P25103 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421589 0.79 CYP4F2 (0.47) CYP4F2CYP4A11SLC5A1SLC5A2SIGMAR1
SCHEMBL1691998 0.72 SMYD3 (0.49) SMN1; SMN2SMYD3NPC1RAB9AKMT2A
SCHEMBL8469011 0.72 SLC5A1 (0.41) MGLLSLC5A1SLC5A2SMN1; SMN2SIGMAR1
SCHEMBL8469013 0.72 SLC5A1 (0.41) MGLLSLC5A1SLC5A2SMN1; SMN2SIGMAR1
SCHEMBL8329361 0.69 CCR5 (0.49) SMN1; SMN2SMYD3KMT2A
SCHEMBL8331069 0.68 CCR5 (0.39) SMN1; SMN2SMYD3KMT2A
SCHEMBL13534476 0.67 SMN1; SMN2 (0.54) SMN1; SMN2SMYD3NPC1RAB9AKMT2A
SCHEMBL18617804 0.66 SLC5A1 (0.37) SLC5A1SLC5A2
SCHEMBL8098235 0.66 MTNR1B (0.54) SLC5A1SLC5A2
SCHEMBL8098232 0.66 MTNR1B (0.54) SLC5A1SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889031-A CONTROLLING CIRCADIAN RHYTHMS BRISTOL-MYERS SQUIBB COMPNAY (US) 1999-03-30 — — US disclosed
US-5753709-A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics BRISTOL-MYERS SQUIBB COMPANY (US) 1998-05-19 — — US disclosed
Send feedback